Shandong Weigao Group Medical Polymer Company Limited (FRA:UK2)

Market Cap	2.91B
Revenue (ttm)	1.73B
Net Income (ttm)	273.49M
Shares Out	n/a
EPS (ttm)	0.06
PE Ratio	10.64
Forward PE	n/a
Dividend	0.02 (3.90%)
Ex-Dividend Date	Jun 2, 2025

Volume	995
Average Volume	398
Open	0.6200
Previous Close	0.6300
Day's Range	0.6200 - 0.6200
52-Week Range	0.4260 - 0.7650
Beta	n/a
RSI	48.82
Earnings Date	Aug 28, 2025

About FRA:UK2

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2000
• Employees: 12,719
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UK2

Financial Performance

In 2024, FRA:UK2's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY